{"id":157668,"date":"2017-11-03T07:21:01","date_gmt":"2017-11-03T07:21:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=157668"},"modified":"2017-11-03T07:21:01","modified_gmt":"2017-11-03T07:21:01","slug":"coronary-artery-disease-therapeutics-industry-treatment-analysisresearchreview-to-2021","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/coronary-artery-disease-therapeutics-industry-treatment-analysisresearchreview-to-2021_157668.html","title":{"rendered":"Coronary Artery Disease Therapeutics Industry \u2013 Treatment Analysis,Research,Review to 2021"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Coronary Artery Disease Therapeutics Market”<\/div>\n<\/div>\n<\/div>\n
WiseGuyReports.Com Publish a New Market Research Report On -\u201cCoronary Artery Disease Therapeutics Industry \u2013 Treatment Analysis,Research,Review to 2021\u201d.<\/div>\n

                           <\/p>\n

The analysts forecast the global coronary artery disease therapeutics market to grow at a CAGR of 5.17% during the period 2017-2021.<\/strong><\/p>\n

Coronary artery disease (CAD)<\/strong> is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries that prevents the supply of an adequate amount of blood supply to the heart. It happens when a coronary artery gets hardened or narrowed due to various reasons such as the build-up of cholesterol or other materials known as plaque on the inner wall of the artery. This build-up is known as atherosclerosis. With passing time, a lesser amount of blood flows through the arteries. As a result heart muscle fails to get the required amount of blood or oxygen.<\/p>\n

 <\/p>\n

Get a Sample Report<\/strong>@<\/em><\/strong>  https:\/\/www.wiseguyreports.com\/sample-request\/2457524-global-coronary-artery-disease-therapeutics-market-2017-2021<\/a><\/p>\n

For more information or any query mail at sales@wiseguyreports.com<\/em><\/strong><\/p>\n

Covered in this report 
<\/strong>The report covers the present scenario and the growth prospects of the global coronary artery disease therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.<\/p>\n

The market is divided into the following segments based on geography: 
<\/strong>• Americas 
• APAC 
• EMEA<\/p>\n

The report, Global Coronary Artery Disease Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.<\/p>\n

Key vendors 
<\/strong>• AstraZeneca 
• Gilead 
• Novartis 
• Pfizer <\/p>\n

Other prominent vendors 
<\/strong>• Bayer, 
• Bristol-Myers Squibb, 
• GlaxoSmithKline, 
• Merck, 
• Mylan, 
• Teva Pharmaceutical Industries <\/p>\n

Market driver 
<\/strong>• Growing geriatric population 
• For a full, detailed list, view our report<\/p>\n

Market challenge 
<\/strong>• Highly genericized market 
• For a full, detailed list, view our report<\/p>\n

Market trend 
<\/strong>• Growing strategic alliances 
• For a full, detailed list, view our report<\/p>\n

Key questions answered in this report 
<\/strong>• What will the market size be in 2021 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?<\/p>\n

 <\/strong><\/p>\n

Ask Query <\/strong>@<\/em><\/strong>  https:\/\/www.wiseguyreports.com\/enquiry\/2457524-global-coronary-artery-disease-therapeutics-market-2017-2021<\/a><\/p>\n

 <\/strong><\/p>\n

Table Of Contents – Major Key Points<\/strong><\/p>\n

PART 01: EXECUTIVE SUMMARY <\/strong><\/p>\n

PART 02: SCOPE OF THE REPORT <\/strong><\/p>\n

PART 03: RESEARCH METHODOLOGY <\/strong><\/p>\n

PART 04: INTRODUCTION 
<\/strong>• Market outline 
• Disease definition 
• Risk factors for CAD 
• Diagnosis 
• Treatment options <\/p>\n

PART 05: MARKET LANDSCAPE 
<\/strong>• Market overview 
• Five forces analysis <\/p>\n

PART 06: PIPELINE LANDSCAPE <\/strong><\/p>\n

PART 07: MARKET SEGMENTATION BY DRUG CLASS 
<\/strong>• Comparison by drug class 
• Beta-blockers 
• Calcium channel blockers 
• Nitrates 
• ACE inhibitors 
• Others 
• Market opportunity <\/p>\n

PART 08: REGIONAL LANDSCAPE 
<\/strong>• Geographical segmentation 
• Regional comparison 
• CAD therapeutics in Americas 
• CAD therapeutics in EMEA 
• CAD therapeutics in APAC 
• Key leading countries 
• Market opportunity <\/p>\n

PART 09: DECISION FRAMEWORK <\/strong><\/p>\n

PART 10: DRIVERS AND CHALLENGES 
<\/strong>• Market drivers 
• Market challenges <\/p>\n

PART 11: MARKET TRENDS 
<\/strong>• Growing strategic alliances 
• Investment inclination toward developing countries <\/p>\n

PART 12: VENDOR LANDSCAPE 
<\/strong>• Competitive landscape <\/p>\n

PART 13: VENDOR ANALYSIS 
<\/strong>• Vendor overview <\/p>\n

PART 14: KEY VENDORS 
<\/strong>• AstraZeneca 
• Gilead 
• Novartis 
• Pfizer <\/p>\n

Continue…….<\/strong><\/p>\n

For more information or any query mail at sales@wiseguyreports.com<\/em><\/strong><\/p>\n

ABOUT US:<\/strong><\/p>\n

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd<\/strong>. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> sales@wiseguyreports.com
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Coronary Artery Disease Therapeutics Market” WiseGuyReports.Com Publish a New Market Research Report On -\u201cCoronary Artery Disease Therapeutics Industry \u2013 Treatment Analysis,Research,Review to 2021\u201d.                             The analysts forecast … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-157668","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/157668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=157668"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/157668\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=157668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=157668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=157668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}